Bayer CropScience is engaged in Agri Care business which primarily includes manufacture, sale and distribution of insecticides, fungicides, herbicide and various other agrochemical products and corn seeds.[1]
History[1]The Bayer group launched its Indian operations in 1958 by setting up an agrochemical manufacturing unit, in which the group has 68.58% stake. Company manufactures and markets crop protection solutions, and trades in seeds on behalf of Bayer Bioscience Pvt Ltd.
| S.No. | Name | Current Price (Rs.) | Price to Earning | Market Capitalization (Rs.Cr.) | Dividend yield (%) | Net Profit latest quarter (Rs.Cr.) | YOY Quarterly profit growth (%) | Sales latest quarter (Rs.Cr.) | YOY Quarterly sales growth (%) | Return on capital employed (%) | Sales (Rs.Cr.) | OPM (%) | Profit after tax (Rs.Cr.) | Profit after tax latest quarter (Rs.Cr.) | Price to book value | Return on assets (%) | Debt to equity |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | UPL | 792.00 | 28.15 | 66786.57 | 0.76 | 612.00 | 209.91 | 12019.00 | 8.38 | 7.66 | 47715.00 | 17.15 | 2372.46 | 484.10 | 2.09 | 0.95 | 0.94 |
| 2. | P I Industries | 3270.30 | 32.84 | 49682.87 | 0.49 | 409.30 | -19.46 | 1872.30 | -15.70 | 22.86 | 7460.70 | 27.18 | 1512.50 | 409.30 | 4.58 | 14.46 | 0.02 |
| 3. | Sumitomo Chemi. | 431.05 | 39.77 | 21493.19 | 0.28 | 177.90 | -6.78 | 914.44 | -5.86 | 25.14 | 3249.74 | 20.16 | 540.43 | 177.90 | 6.74 | 13.91 | 0.02 |
| 4. | Bayer Crop Sci. | 4388.00 | 32.39 | 19721.93 | 2.85 | 152.70 | 12.03 | 1553.40 | -10.60 | 24.80 | 5571.80 | 13.37 | 608.90 | 152.70 | 6.31 | 11.56 | 0.03 |
| 5. | Sharda Cropchem | 826.25 | 16.48 | 7448.63 | 1.09 | 74.35 | 75.22 | 929.11 | 19.59 | 16.50 | 4671.78 | 16.40 | 451.81 | 74.31 | 2.79 | 6.84 | 0.00 |
| 6. | Dhanuka Agritech | 1071.10 | 17.24 | 4827.01 | 0.19 | 93.97 | -20.04 | 598.25 | -8.56 | 28.29 | 2013.83 | 20.12 | 280.01 | 93.97 | 3.13 | 17.27 | 0.02 |
| 7. | Rallis India | 243.50 | 27.70 | 4730.55 | 1.02 | 102.00 | -0.39 | 861.00 | -7.22 | 10.12 | 2770.00 | 11.84 | 170.77 | 97.62 | 2.30 | 4.15 | 0.03 |
| – | Median: 23 Co. | 243.5 | 28.49 | 1865.32 | 0.19 | 19.46 | 4.58 | 456.94 | 5.76 | 13.04 | 1374.5 | 11.41 | 39.66 | 19.21 | 2.3 | 5.4 | 0.27 |
Standalone figures in ₹ crores
| Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 1,452 | 1,038 | 982 | 1,740 | 1,617 | 955 | 792 | 1,631 | 1,738 | 1,057 | 1,046 | 1,915 | 1,553 |
Expenses | 1,214 | 952 | 777 | 1,315 | 1,312 | 827 | 695 | 1,317 | 1,554 | 1,037 | 876 | 1,566 | 1,348 |
Operating Profit | 238 | 85 | 206 | 425 | 305 | 128 | 97 | 314 | 184 | 20 | 171 | 348 | 205 |
Other Income | 14 | 116 | 24 | 21 | 16 | 15 | 29 | 27 | 24 | 32 | 37 | 19 | 14 |
Profit before tax | 229 | 184 | 195 | 406 | 306 | 124 | 105 | 316 | 190 | 34 | 168 | 335 | 200 |
Tax % | 29% | 27% | 19% | 19% | 27% | 25% | 9% | 20% | 28% | -2% | 15% | 17% | 24% |
Net Profit | 163 | 134 | 158 | 328 | 223 | 93 | 96 | 254 | 136 | 34 | 143 | 279 | 153 |
EPS in Rs | 36.18 | 29.93 | 35.27 | 73.09 | 49.60 | 20.72 | 21.36 | 56.56 | 30.33 | 7.61 | 31.89 | 62.01 | 33.98 |
Standalone Figures in ₹ Crores / Yearly
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 3,188 | 3,660 | 2,769 | 2,803 | 2,710 | 3,167 | 3,609 | 4,261 | 4,734 | 5,140 | 5,106 | 5,473 | 5,572 |
Expenses | 2,768 | 3,144 | 2,334 | 2,389 | 2,300 | 2,684 | 2,883 | 3,450 | 3,923 | 4,216 | 4,147 | 4,783 | 4,827 |
Operating Profit | 419 | 516 | 435 | 414 | 410 | 483 | 726 | 812 | 812 | 924 | 959 | 691 | 745 |
Other Income | 91 | 88 | 82 | 70 | 39 | 51 | -64 | 69 | 112 | 168 | 76 | 118 | 102 |
Interest | 5 | 5 | 10 | 7 | 11 | 10 | 14 | 13 | 13 | 22 | 20 | 17 | 18 |
Depreciation | 65 | 25 | 25 | 29 | 33 | 44 | 65 | 74 | 64 | 80 | 74 | 85 | 91 |
Profit before tax | 441 | 574 | 482 | 448 | 404 | 480 | 583 | 794 | 847 | 990 | 941 | 707 | 737 |
Net Profit | 290 | 383 | 315 | 291 | 300 | 337 | 474 | 493 | 645 | 758 | 740 | 568 | 609 |
EPS in Rs | 79.06 | 104.59 | 89.13 | 82.31 | 87.41 | 98.18 | 105.58 | 109.72 | 143.58 | 168.71 | 164.77 | 126.38 | 135.49 |
Dividend Payout % | 7% | 20% | 19% | 21% | 21% | 18% | 24% | 105% | 104% | 77% | 85% | 99% | – |
Standalone figures in ₹ crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 37 | 37 | 35 | 35 | 34 | 34 | 45 | 45 | 45 | 45 | 45 | 45 | 45 |
Reserves | 1,706 | 1,996 | 1,804 | 2,021 | 1,744 | 2,205 | 2,528 | 2,505 | 2,479 | 2,667 | 2,804 | 2,806 | 3,079 |
Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 26 | 86 | 74 | 47 | 105 | 102 |
Other Liabilities | 645 | 740 | 597 | 769 | 756 | 1,310 | 1,262 | 1,663 | 1,742 | 1,893 | 1,701 | 2,290 | 1,966 |
Total Liabilities | 2,387 | 2,773 | 2,437 | 2,825 | 2,535 | 3,549 | 3,836 | 4,239 | 4,353 | 4,679 | 4,597 | 5,246 | 5,191 |
Fixed Assets | 228 | 322 | 290 | 342 | 334 | 440 | 468 | 425 | 468 | 462 | 414 | 470 | 585 |
Gross Block | 479 | 434 | 314 | 392 | 416 | 581 | 668 | 682 | 743 | 794 | 790 | 875 | – |
Accumulated Depreciation | 251 | 112 | 24 | 50 | 81 | 140 | 199 | 257 | 275 | 332 | 376 | 406 | – |
CWIP | 217 | 1 | 17 | 24 | 36 | 47 | 56 | 76 | 98 | 109 | 119 | 119 | 9 |
Investments | 4 | 29 | 68 | 50 | 0 | 0 | 41 | 52 | 38 | 41 | 54 | 35 | 41 |
Other Assets | 1,939 | 2,422 | 2,062 | 2,410 | 2,164 | 3,062 | 3,270 | 3,686 | 3,749 | 4,066 | 4,010 | 4,622 | 4,557 |
Total Assets | 2,387 | 2,773 | 2,437 | 2,825 | 2,535 | 3,549 | 3,836 | 4,239 | 4,353 | 4,679 | 4,597 | 5,246 | 5,191 |
Standalone Figures in ₹ Crores / Yearly
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operating Activity | 282 | 200 | 206 | 157 | 121 | 433 | 666 | 687 | 216 | 609 | 952 | 262 |
Cash from Investing Activity | -290 | 485 | 16 | -8 | 38 | -113 | -29 | 7 | 64 | 83 | 0 | 86 |
Cash from Financing Activity | -480 | -42 | -590 | -73 | -581 | -158 | -148 | -556 | -703 | -613 | -656 | -619 |
Net Cash Flow | -488 | 644 | -367 | 76 | -421 | 162 | 489 | 138 | -424 | 79 | 296 | -272 |
Standalone Figures in ₹ Crores / Yearly
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 47 | 57 | 53 | 72 | 89 | 81 | 73 | 65 | 77 | 69 | 69 | 63 |
Inventory Days | 98 | 85 | 169 | 178 | 175 | 294 | 206 | 226 | 235 | 268 | 222 | 319 |
Days Payable | 51 | 40 | 52 | 67 | 67 | 164 | 101 | 142 | 127 | 129 | 87 | 148 |
Cash Conversion Cycle | 94 | 102 | 171 | 184 | 197 | 211 | 177 | 149 | 185 | 208 | 204 | 234 |
Working Capital Days | 88 | 53 | 92 | 104 | 134 | 116 | 77 | 61 | 84 | 86 | 78 | 88 |
ROCE % | 24% | 31% | 25% | 23% | 22% | 25% | 30% | 31% | 31% | 34% | 34% | 25% |
Direct from BSE filings, auto-summarised
External media mentions & references
Nov 2025
Aug 2024
Jun 2023
Jun 2022
Nov 2021
May 2021
Nov 2020
May 2020
Nov 2019
May 2019
Nov 2018
Jun 2018
Aug 2017
Feb 2017
Jul 2016
Nov 2015
Stock Analysis
Bayer CropScience Limited is a significant player in India's agricultural sector, primarily engaged in the Agri-Care business. Its operations include the manufacturing, sale, and distribution of a wide range of agrochemicals, such as insecticides, fungicides, and herbicides, alongside corn seeds.
The company is focusing on innovation with product launches like BICOTA® for paddy cultivation. Additionally, a strategic partnership via an MoU with DCM Shriram aims to enhance sustainable and future-ready agriculture practices, potentially boosting farmer productivity and climate resilience.
Currently no data available for Order Book.
Bayer CropScience is facing significant regulatory headwinds, with multiple penalty orders issued by GST and Customs authorities totaling over ₹162.51 million. These penalties, stemming from issues related to input tax credit and outward supply regulations across various financial years, present a persistent compliance challenge and potential financial risk.
No specific future dates were mentioned in the current filing. Past disclosures indicated a board meeting on November 7, 2025, for Q2 results and dividend declaration. The upcoming results for the quarter ended December 31, 2025, will be key.
Corporate Announcements
